SCHEMBL6795488

SCHEMBL6795488

COC(=O)[C@H](C)c1ccc(N2CCN(C)C2=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNA2 P20248 9/20 0.54
CDK2 P24941 9/20 0.54
CCNA1 P78396 9/20 0.54
HDAC1 Q13547 2/20 0.41
HPGD P15428 1/20 0.40
ALDH1A1 P00352 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
TP53 P04637 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
NPC1 O15118 1/20 0.39
PGR P06401 1/20 0.39
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.39
PKM P14618 1/20 0.39
NFKB1 P19838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5727685 1.00 CCNA2 (0.54) CCNA2CDK2CCNA1HDAC1HPGD
SCHEMBL6790358 1.00 CCNA2 (0.54) CCNA2CDK2CCNA1HDAC1HPGD
SCHEMBL5769663 0.85 CCNA2 (0.53) CCNA2CDK2CCNA1HDAC1HRH3
SCHEMBL5726470 0.85 CCNA2 (0.53) CCNA2CDK2CCNA1HDAC1HRH3
SCHEMBL5727140 0.85 CCNA2 (0.53) CCNA2CDK2CCNA1HDAC1HRH3
SCHEMBL24451811 0.80 CCNA2 (0.46) CCNA2CDK2CCNA1HDAC1ALDH1A1
SCHEMBL6796684 0.79 CCNA2 (0.53) CCNA2CDK2CCNA1HPGDALDH1A1
SCHEMBL6788871 0.79 CCNA2 (0.53) CCNA2CDK2CCNA1HPGDALDH1A1
SCHEMBL5726513 0.79 CCNA2 (0.53) CCNA2CDK2CCNA1HPGDALDH1A1
SCHEMBL6784455 0.76 HIF1A (0.54) CCNA2CDK2CCNA1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040235919-A1 Phenylacetamido-thiazole derivatives, process for the preparation and their use as antitumor agents PFIZER ITALIA S.R.I. (IT) 2004-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235919-A1 Phenylacetamido-thiazole derivatives, process for the preparation and their use as antitumor agents CDK2, CDK1, CDKN1A CCNA2 31/4885CDK2 1/4885CCNA1 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.